B.C. Reg. 111/2023: Amendments to the Pharmacists Regulation and the Pharmacy Operations General Regulation
Made under the Health Professions Act
How does this rule affect your organization? One Click reads it against your profile and tells you, on Canada Federal Legislative Tracking. See plans →
Get alerted when the next rule lands
New rules land on their own schedule. Pick how you want to hear about them — we email you when one appears.
Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.
The rule, in full
803 words as published, April 26, 2023. View the original →
B.C. Reg. 111/2023, deposited April 25, 2023, under the HEALTH PROFESSIONS ACT [section 12 (2) and (4)] and PHARMACY OPERATIONS AND DRUG SCHEDULING ACT [section 34.1]. Ministerial Order M114/2023, dated April 24, 2023. I, Adrian Dix, Minister of Health, order that (a) effective June 1, 2023, the Pharmacists Regulation, B.C. Reg. 417/2008, is amended as set out in the attached Appendix 1, (b) with respect to the amendment referred to in paragraph (a) of this order, the notice period for the purposes of section 12 (3) and (4) of the Health Professions Act is 15 days, and (c) effective June 1, 2023, the Pharmacy Operations General Regulation, B.C. Reg. 43/2018, is amended as set out in the attached Appendix 2. — A. DIX, Minister of Health.
Appendix 1
1 Section 1 of the Pharmacists Regulation, B.C. Reg. 417/2008, is amended in paragraph (a.1) of the definition of "practice of pharmacy" by adding "and treating" after "and preventing". 2 Section 1 is amended in the definition of "substance" by striking out "Schedule I, IA, II or IV" and substituting "Schedule I, IA or II". 3 Section 4 (1) is amended (a) by repealing paragraph (a) and substituting the following: (a) prescribe, for the purpose of contraception or emergency contraception, a drug specified in Schedule I of the Drug Schedules Regulation; , (b) by adding the following paragraphs: (a.1) make a diagnosis identifying, as the cause of the signs or symptoms of an individual, a disease, disorder or condition that is shown in Column 1 of Schedule A, if all of the following conditions are met: (i) the disease, disorder or condition, in the form indicated by the individual’s signs and symptoms, (A) presents a low risk of masking an underlying disease, disorder or condition, and (B) can be readily diagnosed without the need for laboratory or imaging tests; (ii) the individual’s signs or symptoms can be reasonably expected to resolve with only short-term or episodic treatment; (a.2) for the purpose of treating a disease, disorder or condition diagnosed under paragraph (a.1), prescribe a drug that is (i) specified in Schedule I of the Drug Schedules Regulation, and (ii) within a drug category shown opposite the disease, disorder or condition in Column 2 of Schedule A of this regulation; , and (c) in paragraphs (b) and (c) by striking out "Schedule I, IA, II or IV" and substituting "Schedule I, IA or II". 4 Section 4.1 is amended by renumbering subsection (1) as subsection (1.1) and by adding the following subsection: (1) A registrant may perform an activity described in section 4 (1) (a), (a.1) or (a.2) only if (a) standards, limits and conditions have been established, under section 19 (1) (k) or (l) of the Act, respecting (i) the making of diagnoses for the purposes of section 4 (1) (a.1), and (ii) the prescribing, by registrants, of contraceptives and emergency contraceptives, and of drugs referred to in Schedule A, and (b) the standards, limits and conditions described in paragraph (a) are established on the recommendation of a committee that (i) is established under section 19 (1) (t) of the Act, (ii) has the duty and power to develop, review and recommend those standards, limits and conditions, and (iii) includes at least one medical practitioner who is confirmed by the College of Physicians and Surgeons of British Columbia as suitable to be a member of the committee. 5 The following Schedule is added:
Schedule A
(section 4) Column 1 Disease, disorder or condition | Column 2 Drug Category Acne | Topical drugs Allergic rhinitis | Intranasal drugs, including antihistamine drugs Ophthalmic drugs, including antihistamine drugs Oral antihistamine drugs Conjunctivitis (allergic, bacterial or viral) | Ophthalmic drugs Dermatitis (allergic, atopic, contact, diaper or seborrheic) | Topical drugs Dysmenorrhea | Non-steroidal anti-inflammatory drugs Dyspepsia | Gastric acid-reducing drugs Fungal infections (Onychomycosis, Tinea corporis infection, Tinea cruris infection or Tinea pedis infection) | Topical drugs Gastroesophageal reflux disease | Gastric acid-reducing drugs Headache | Non-steroidal anti-inflammatory drugs Hemorrhoids | Topical drugs Herpes labialis | Topical drugs, including antiviral drugs Other types of antiviral drugs Impetigo | Topical drugs Musculoskeletal pain | Non-steroidal anti-inflammatory drugs Nicotine dependence | Nicotine cessation drugs Oral ulcers (canker sores or aphthous ulcers) | Topical drugs Oropharyngeal candidiasis | Antifungal drugs Shingles | Antiviral drugs Threadworms or pinworms | Anthelmintic drugs Urinary tract infection (uncomplicated) | Antibiotic drugs Urticaria, including insect bites | Topical drugs, including antihistamine drugs Other types of antihistamine drugs Vaginal candidiasis | Antifungal drugs
Appendix 2
1 Section 2 (d) of the Pharmacy Operations General Regulation, B.C. Reg. 43/2018, is repealed and the following substituted: (d) pharmacists; . 2 Section 3 is amended by striking out "who is authorized to prescribe a drug listed in section 2 (d) of this regulation for the purpose of emergency contraception".
Documents
- The text in The British Columbia Gazette · April 26, 2023